Global Endometriosis Market and Competitive Landscape to 2024

DUBLIN, June 18, 2020 /PRNewswire/ -- The "Global Endometriosis Market and Competitive Landscape - 2020" report has been added to's offering.

This report provides comprehensive insights into the Endometriosis pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Endometriosis market size and drug sales. It also provides insights into Endometriosis epidemiology and late stage pipeline.

This research covers the following:

Endometriosis treatment options, Endometriosis late stage clinical trials pipeline, Endometriosis prevalence by countries, Endometriosis market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries US, Germany, France, Italy, Spain, UK, Japan, Europe, Global (G7 Countries).

Research Scope:

    --  Countries: US, Germany, France, Italy, Spain, UK, Japan, Europe, Global
    --  Endometriosis pipeline: Find out drugs in clinical trials for the
        treatment of Endometriosis by development phase 3, phase 2, and phase 1,
        by pharmacological class and company
    --  Endometriosis epidemiology: Find out the number of patients diagnosed
        (prevalence) with Endometriosis by countries
    --  Endometriosis drugs: Identify key drugs marketed and prescribed for
        Endometriosis in the US, including trade name, molecule name, and
    --  Endometriosis drugs sales: Find out the sales value for Endometriosis
        drugs by countries
    --  Endometriosis market valuations: Find out the market size for
        Endometriosis drugs in 2019 by countries. Find out how the market
        advanced from 2016 and forecast to 2024
    --  Endometriosis drugs market share: Find out the market shares for key
        drugs by countries

Benefits of this Research:

    --  Evaluate commercial market opportunities for Endometriosis drugs
    --  Synthesize insights for business development & licensing
    --  Track market size, competitor drug sales, market shares in the
        Endometriosis market
    --  Develop in-depth knowledge of competition and markets
    --  Analyze Endometriosis drug sales data to update your brand planning
    --  Develop tactics and strategies to take advantage of opportunities in the
    --  Track Market Events and Trends and analyze key events in the
        Endometriosis market
    --  Develop forecast models, healthcare frameworks, or economic models

    --  Answer key business questions; supports decision making in R&D to long
        term marketing strategies

Key Topics Covered:

1. Endometriosis Treatment Options

2. Endometriosis Pipeline Insights
2.1. Endometriosis Phase 3 Clinical Trials
2.2. Endometriosis Phase 2 Clinical Trials
2.3. Endometriosis Phase 1 Clinical Trials

3. Endometriosis Epidemiology Analysis by Countries

4. US Endometriosis Market Insights
4.1. Marketed Drugs for Endometriosis in US
4.2. US Endometriosis Market Size & Forecast
4.3. US Endometriosis Drugs Sales & Forecast
4.4. US Endometriosis Market Share Analysis

5. Germany Endometriosis Market Insights
5.1. Marketed Drugs for Endometriosis in Germany
5.2. Germany Endometriosis Market Size & Forecast
5.3. Germany Endometriosis Drugs Sales Forecast
5.4. Germany Endometriosis Market Share Analysis

6. France Endometriosis Market Insights
6.1. Marketed Drugs for Endometriosis in France
6.2. France Endometriosis Market Size & Forecast
6.3. France Endometriosis Product Sales Forecast
6.4. France Endometriosis Market Share Analysis

7. Italy Endometriosis Market Insights
7.1. Marketed Drugs for Endometriosis in Italy
7.2. Italy Endometriosis Market Size & Forecast
7.3. Italy Endometriosis Product Sales Forecast
7.4. Italy Endometriosis Market Share Analysis

8. Spain Endometriosis Market Insights
8.1. Marketed Drugs for Endometriosis in Spain
8.2. Spain Endometriosis Market Size & Forecast
8.3. Spain Endometriosis Product Sales Forecast
8.4. Spain Endometriosis Market Share Analysis

9. UK Endometriosis Market Insights
9.1. Marketed Drugs for Endometriosis in UK
9.2. UK Endometriosis Market Size & Forecast
9.3. UK Endometriosis Product Sales Forecast
9.4. UK Endometriosis Market Share Analysis

10. Europe Endometriosis Market Insights
10.1. Europe Endometriosis Market Size & Forecast
10.2. Europe Endometriosis Product Sales Forecast
10.3. Europe Endometriosis Market Share Analysis

11. Japan Endometriosis Market Insights
11.1. Marketed Drugs for Endometriosis in Japan
11.2. Japan Endometriosis Market Size & Forecast
11.3. Japan Endometriosis Product Sales Forecast
11.4. Japan Endometriosis Market Share Analysis

12. Global Endometriosis Market Insights
12.1. Global Endometriosis Market Size & Forecast
12.2. Global Endometriosis Product Sales Forecast
12.3. Global Endometriosis Market Share Analysis

13. Research Methodology

For more information about this report visit

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:

SOURCE Research and Markets